BIIB Financial Facts
Other: 98.6MDiluted earnings per share attributable to Biogen Idec Inc.: 219.4M
See Full Income Statement
Total current liabilities: 2.5B
Common stock, par value $0.0005 per share: 100K
See Full Balance Sheet
Biogen Idec Inc. (BIIB) Earnings
|
Expand Research on BIIB
| Next EPS Date | 7/23/24 *Est. | EPS Growth Rate | +7.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +3.8% | Revenue Growth Rate | -6.9% *Last Qtr. |
| Average % Move 1-Wk after EPS | -4.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/3/22 |  |
Q122 | $3.62 | $4.38 | -$0.76 | $2.53B | $2.5B | = |  | | Details |
2/3/21  |
Q420 | $4.58 | $4.87 | -$0.29 | $2.85M | $2.8M |  |
| | Details | |
| 2/13/24 | Q423 | $2.95 | $3.18 | -$0.23 | $2.4B | $2.47B | = | | | Details | |
| 1/25/18 | |
Q417 | $5.26 | $5.45 | -$0.19 | $3.31B | $3.08B | = | | | Details |
| 4/23/14 |
|
Q114 | $2.47 | $2.56 | -$0.09 | $2.1B | $2B | |
| | Details |
| 4/24/15 |
|
Q115 | $3.82 | $3.91 | -$0.09 | $2.56B | $2.66B | |
| | Details |
| 5/1/12 |
|
Q112 | $1.40 | $1.48 | -$0.08 | $1.29B | $1.31B | = | | | Details |
| 1/28/13 |
|
Q412 | $1.40 | $1.46 | -$0.06 | $1.4B | $1.38B | |
| | Details |
